Carrie Brownstein is Chief Medical Officer of Zentalis Pharmaceuticals, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Shattuck Labs, Inc.
21 Jun 24
144
Zentalis Pharmaceuticals, Inc.
2 Feb 24
4
Zentalis Pharmaceuticals, Inc.
6 Oct 23
144
Zentalis Pharmaceuticals, Inc.
4 Oct 23
4
Shattuck Labs, Inc.
31 May 23
4
Zentalis Pharmaceuticals, Inc.
1 Feb 23
4
Zentalis Pharmaceuticals, Inc.
3 Oct 22
3
Zentalis Pharmaceuticals, Inc.
3 Oct 22
4
Shattuck Labs, Inc.
10 Jun 22
4
Shattuck Labs, Inc.
17 Nov 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Jun 24 | STTK Shattuck Labs | Stock Option Common Stock | Grant | Acquire A | No | No | 4.37 | 27,700 | 121.05 k | 27,700 |
4 Oct 23 | ZNTL Zentalis Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 19.9102 | 1,722 | 34.29 k | 105,685 |
4 Oct 23 | ZNTL Zentalis Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 19.4265 | 8,906 | 173.01 k | 107,407 |
26 May 23 | STTK Shattuck Labs | Stock Option Common Stock | Grant | Acquire A | No | No | 2.72 | 40,258 | 109.50 k | 40,258 |